Упрощенная HTML-версия
140
149. Andrew I. Genetic and Acquired Determinants of Individual Variability
of Response to Antiplatelet Drugs / Andrew I. Schafer, MD // Circulation. – 2003.
– Vol. 108. – p. 910.
150. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of
randomised trials of antiplatelet therapy for prevention of death, myocardial
infarction, and stroke in high risk patients // BMJ. – 2002. – Vol. 324 (7329). – p.
71-86.
151. Arbustini E. Coronary atherosclerotic plaques with and without thrombus
in ischemic heart syndromes: a morphologic, immunohistochemical and
biochemical study / E. Arbustini, M. Grasso, M. Diegoli et al. // Am. J. Cardiol. -
1991. – Vol. 68. – № 7. – P. 36B-50B.
152. Aronow W.S. Antiplatelet agents in the prevention of cardiovascular
morbidity and mortality in older patients with vascular disease / W.S. Aronow //
Drugs Aging. – 1999. – Vol. 15 (2). – P. 91-101.
153. Barakat K. Acute myocardial infarction in women: contribution of
treatment variables to adverse outcome / К. Barakat, P. Wilkinson, A. Suliman et
al. // Amer. Heart J. – 2000. – № 140 (5). – Р. 740-746.
154. Berger P.B. The thienopyridines in coronary artery disease / P.B.
Berger // Curr. Cardiol Rep. – 1999. – Vol. 1 (3). – P. 192-198.
155. Bhatt D.L. Clopidogrel added to aspirin versus aspirin alone in secondary
prevention and high-risk primary prevention: rationale and design of the
Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization,
Management, and Avoidance (CHARISMA) trial / D.L. Bhatt, E.J. Topol // Am.
Heart J. – 2004. – Vol. 148 (2). – Р. 263-268.
156. Bhatt D.L. Clopidogrel and aspirin versus aspirin alone for the
prevention of atherothrombotic events / D.L. Bhatt, K.A. Fox, W. Hacke et al. // N.
Engl. J. Med. – 2006. – Vol. 354 (16). – Р. 1706-1717.
157. Bhatt D.L. Reduction in need for hospitalization for recurrent ischemic
events and bleeding with clopidogrel instead of aspirin / D.L. Bhatt, A.T. Hirsch,
P.A. Ringleb et al.// Amer. Heart J. – 2000. – Vol. 140. – P. 67-73
158. Bogousslavsky J. Benefit of ADP receptor antagonists in
atherothrombotic patients: new evidence / J. Bogousslavsky // Cerebrovasc. Dis. –
2001. – Vol. 11 (Suppl 2). – Р. 5-10.